Hotgen
Daxing · Founded 2005
About Hotgen
Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation. Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Total funding: $5.0M
- Funding stage: IPO
- Last round: Series B (Jan 2019)
- Ticker: sse:688068
- Website: hotgen.com.cn
- Phone: 400-815-1117
Industries & Categories
Biotechnology, Manufacturing, Medical, Public Safety
Social Profiles
Canonical: https://fsome.com/organization/hotgen-2216187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.